Anzeige
Mehr »
Login
Sonntag, 19.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
100-Milliarden-Dollar-Marke: Wie die strategische Vision eines Unternehmens historischem Meilenstein passt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
534 Leser
Artikel bewerten:
(2)

RTG Consulting Group Announces New Win with The Shenzhen Museum of Contemporary Art and Urban Planning (MOCAUP)

Finanznachrichten News

SHANGHAI, Dec. 17, 2020 /PRNewswire/ -- RTG Consulting Group (RTG), has been appointed by Shenzhen Museum of Contemporary Art and Urban Planning (MOCAUP) as their official brand strategy partner. The engagement began with deep consumer and corporate partner insights work and transition to comprehensive brand positioning, brand awareness, and brand engagement services.

Yan Weixin, the Curator of MOCAUP said, "As an industry pioneer, MOCAUP has first employed a brand new operation model in 2019 to organize art events and also urban cultural activities. Up until now, it has developed a great advantage in independent activity-planning and developing crossover among different industries. We believe MOCAUP deserves to be entitled as the new "Global Iconic Art Space". Meanwhile, MOCAUP is also aiming to inspire audience with art forms, deliver spirit through culture, encourage people's innovative thinking and ultimately, promote the development of urban culture." He also said, "Through public bidding, we have identified an excellent partner in RTG Consulting Group. We believe the RTG Group of services will be instrumental in bringing the MOCAUP brand to another level both domestically and abroad."

Angelito Tan, Founding Partner and CEO RTG Group Asia, the parent company of RTG Consulting Group, said, "We are excited to be a part of the dynamic growth taking place in Shenzhen as the city is set to be a major hub for Greater China. We recognize the importance of the Shenzhen Museum of Contemporary Art and Urban Planning (MOCAUP) role in bringing quality content to Chinese patrons, as well as a demonstration of China's emerging role as a global leader in arts & culture. We are honored to have been chosen as a strategic partner."

About MOCAUP

The Shenzhen Museum of Contemporary Art and Urban Planning (MOCAUP) is a new culture and art landmark of Shenzhen. As one of the 60 iconic constructive projects in Shenzhen's 12th Five-Year Plan, it is a non-profit organization of "the common good, academia and service".

The venue is located in the center of Futian Cultural District, covering an area of 30,000 square meters, with a total construction area of 90,000 square meters. It is a platform for promoting the communication and interaction between Chinese contemporary art and international contemporary art, a base for conducting contemporary art theory and academic research, and a place for aesthetic education and citizen culture enrichment to the public.

About RTG Consulting Group

RTG Consulting Group is a leading business consultancy specialized in advising senior executives of the world's most well-known brands and public institutions. RTG comprises of three independent divisions:

  • RTG Intuition (business intelligence)
  • RTG Solutions (business strategy)
  • RTG Inspire (marketing communications)

We are headquartered in Shanghai, with offices in Beijing, Hong Kong and Singapore.

Our core philosophy is grounded in 'Pursuing Betterment'. As individuals, as teams, and collectively as a company, we strive to make a positive impact not only for our brands, but for the world around us. This philosophy is supported by our three pillars: Purpose, Passion, and Perseverance.

For more information, please visit www.rtgconsulting.com

RTG Consulting Group is a subsidiary of RTG Group Asia (www.rtggroupasia.com)

Photo - https://mma.prnewswire.com/media/1386114/MOCAUP_Daytime_Outdoor_Scene.jpg

© 2020 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.